Last updated on June 2018

Sequential Application of Yisaipu and DMARDs in Treating Mild-to-Moderate AS


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Ankylosing spondylitis
  • Age: - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • 1.Clinical diagnosis of Ankylosing Spondylitis(AS) based on modified New York diagnostic criteria for AS (1984) 2.At the mild-to-moderate stage of AS disease 3.At the active phase of AS disease

Exclusion Criteria:

  • 1.Active tuberculosis, hepatitis, tumors, infection diseases or combine with other rheumaimmune systemic diseases or osteoarthritis diseases 2.Pregnant or breastfeeding women

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.